Business
PTX-200 AML Trial Progresses to Next Dose Level
PTX-200 AML Trial Progresses to Next Dose Level
About this update from Prescient Therapeutics Limited
[{"type":"text","content":"Prescient Therapeutics Ltd has released a press release. View Attachment","length":244,"tagName":"div"}]